Answers are grounded in this paper and cite their sources.
Clostridium difficile (C. difficile) is a formidable pathogen causing various symptoms ranging from asymptomatic colonization to fulminant colitis among the elderly. C. difficile associated mortality rate has quadrupled in the last five years. A recent 10 year-literature review was conducted to determine a practical approach for elderly patients with C. difficile infection (CDI) in post-acute settings (PAS). Risk factors for CDI include antibiotic use, age over 65 years old, a prior history of CDI, institutionalization, and use of protein pump inhibitors (PPIs) or H-2 blockers. Diagnostic testing to confirm CDI can be challenging because of the relatively low sensitivity of most commercially available tests. Strategies for the cost-effective management and prevention of CDI include surveillance of at-risk patients with appropriate testing, contact precaution of suspected patients, discontinuation of PPIs or H-2 blockers in selected patients, use of probiotics, and antibiotic stewardship. Treatment and management should be individualized based on risk factors, symptom severity, comorbidities, and history of prior CDI.
No takes yet. Share an insight, caveat, or question.
Myunghan Choi Melvin Hector (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: